Suppr超能文献

等待肝脏再次移植期间的死亡率:终末期肝病模型(MELD)评分的可预测性

Mortality while awaiting liver retransplantation: predictability of MELD scores.

作者信息

Watt K D S, Menke T, Lyden E, McCashland T M

机构信息

Internal Medicine/Hepatology, University of Nebraska Medical Center, Omaha, Nebraska, USA.

出版信息

Transplant Proc. 2005 Jun;37(5):2172-3. doi: 10.1016/j.transproceed.2005.03.004.

Abstract

INTRODUCTION

Model for End-stage Liver Disease (MELD) scores at the time of listing on the transplant waiting list have been shown to accurately predict 3-month mortality in adults. There is no data assessing the accuracy of the MELD scores in predicting mortality of patients awaiting liver retransplantation. We sought to determine the outcome of patients listed for retransplantation at a single center and the accuracy of MELD scores in predicting mortality on the transplant waiting list.

METHODS

A retrospective review of adult patients at a single center listed for a second liver transplantation during the years 1993 to 2000. MELD scores and a concordance statistic were calculated at the time of initial listing and initial transplant as well as the time of relisting for a second transplant and at 2, 4, 6, 8, 12, and 24 weeks after relisting.

RESULTS

Of the 63 patients in the study, 43 (68%) received a second transplant, and 20 (32%) died while awaiting retransplantation. Of the patients receiving a second transplant, 13 (30%) died within 1 year of receiving the transplant. The most common cause of death on the waiting list was sepsis (50%), hepatorenal syndrome (20%), and multiorgan failure (10%), whereas the majority of deaths posttransplantation were sepsis-related (69%). At the time of relisting the c-statistic for MELD scores predicting death after 1 week on the waiting list was 0.78 (P = .007). After 3 months on the waiting list, the c-stat was largely unchanged (0.76, P = .04).

CONCLUSIONS

We have shown that MELD scores may predict mortality on the transplant waiting list for patients listed for a second transplant.

摘要

引言

在移植等待名单上登记时的终末期肝病模型(MELD)评分已被证明能准确预测成人的3个月死亡率。目前尚无数据评估MELD评分在预测等待肝再次移植患者死亡率方面的准确性。我们试图确定在单一中心登记进行再次移植的患者的结局,以及MELD评分在预测移植等待名单上死亡率方面的准确性。

方法

对1993年至2000年期间在单一中心登记进行第二次肝移植的成年患者进行回顾性研究。在初次登记和初次移植时,以及再次登记进行第二次移植时和再次登记后2、4、6、8、12和24周计算MELD评分和一致性统计量。

结果

该研究中的63例患者中,43例(68%)接受了第二次移植,20例(32%)在等待再次移植期间死亡。在接受第二次移植的患者中,13例(30%)在接受移植后1年内死亡。等待名单上最常见的死亡原因是败血症(50%)、肝肾综合征(20%)和多器官功能衰竭(10%),而移植后大多数死亡与败血症相关(69%)。再次登记时,MELD评分预测等待名单上1周后死亡的c统计量为0.78(P = 0.007)。在等待名单上3个月后,c统计量基本未变(0.76,P = 0.04)。

结论

我们已经表明,MELD评分可能预测等待第二次移植的患者在移植等待名单上的死亡率。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验